Jeffrey Fowler, MD

The James Cancer Center
Jeffrey Fowler

Clinical Expertise

  • Cervical Cancer
  • Endometrial Cancers
  • Gynecologic Cancers
  • Gynecologic Oncology
  • Minimally Invasive Surgical Procedures
  • Ovarian Cancers
  • Reproductive Health
  • Robotics
  • Uterine Cancers
  • Vaginal Cancers
  • Vulvar Cancers
  • Women's Health
Insurance Information



Make an Appointment


I am a professor of gynecologic oncology at The Ohio State University and have been in practice since 1991. I have extensive expertise in the latest surgical techniques including radical pelvic surgery, pelvic reconstruction and minimally invasive surgery including laparoscopic and robotic surgery. I am also the medical director for the Robotic Surgery Program at The Ohio State University Medical Center. I have taught these techniques to other surgeons locally, nationally and internationally. I was rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016 and 2017. I have served as chief of staff for the James Cancer Hospital and currently serve as vice-chair of the Department of Obstetrics and Gynecology.

I grew up in Michigan and attended Kalamazoo College and then graduated from Northwestern University Medical School in Chicago. I completed my residency at The Ohio State University College of Medicine and pursued a fellowship in gynecologic oncology at the UCLA School of Medicine and Cedars-Sinai in Los Angeles. After fellowship, I joined the faculty of the University of Minnesota Hospital and Clinic as an assistant professor. In 1997, I returned to The Ohio State University College of Medicine as an associate professor of obstetrics and gynecology and served as director of the Division of Gynecologic Oncology through 2010. In 2001, I was named the inaugural holder of the John G. Boutselis Chair in Gynecologic Oncology, and in 2002 was promoted to full professor.

I represented The Ohio State University in many leadership roles. I serve as a board examiner for general obstetrics and gynecology and gynecologic oncology sub-specialty oral exams for the American Board of Obstetrics and Gynecology (ABOG) and completed a six-year term as board member for ABOG’s Division of Gynecologic Oncology. I served on the Board of Governors of the American College of Surgeons and most recently as the president of the Society of Gynecologic Oncology.

I have authored or co-authored more than 180 journal articles and numerous book chapters and abstracts presented at scholarly meetings. I am a member of the editorial boards for Gynecologic Oncology and the Journal of Robotic Surgery. My primary research interests have been in advancing the state of the art of surgery in gynecologic oncology including minimally invasive surgery (first laparoscopy and now robotics), radical pelvic surgery and pelvic reconstructive surgery.

I have received several awards recognizing my excellence in medical student and resident teaching at Ohio State. I have also been recognized for my research presentations. I have been listed among the "Best Doctors in America" for the past 20 years.

Education and Background


  • Northwestern University Medical School

    Chicago, IL


  • OB/GYN / Gynecological Oncology

    UCLA Medical Center

    Los Angeles, CA

Board Certifications

  • American Board of OB/GYN
  • American Board of OB/GYN (Subspecialty: Gynecologic Oncology)

Academic Department

I see patients at

JamesCare Gynecologic Oncology at Mill Run

3651 Ridge Mill Drive, Hilliard, Ohio 43026


Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Fowler has reported no financial relationships with medical device, research and/or drug companies.


  • Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations.

    Blazer KR, Ditsch N, Godwin AK, Hogervorst FBL, Investigators K, Montagna M, Rashid MU, Robson M, Hamann U, Kruse TA, Leslie G, Blok MJ, de la Hoya M, De Leeneer K, Velazquez C, Galvão HCR, Lindor NM, Skytte AB, Sukiennicki G, Friedman E, Berger A, Claes KBM, Gauthier-Villars M, Miller A, Ong KR, Schmutzler RK, Yannoukakos D, Kwong A, Engert S, Lasa A, Moysich KB, Nussbaum RL, Schmidt AY, Thomas A, van Asperen CJ, Teo SH, Adlard J, Brewer C, Buys SS, Korach J, Lubinski J, Meindl A, Snape K, Steele L, Parsons MT, Longy M, Mulligan AM, Radice P, Side LE, Steinemann D, Szabo CI, Van Heetvelde M, Park SK, Buecher B, Diez O, Easton DF, Faivre L, Konstantopoulou I, Manoukian S, Senter L, Caliebe A, Campbell I, Gutierrez-Barrera A, Henderson A, Toland AE, Solano AR, Pohl E, Antoniou AC, Benitez J, Bonanni B, Izquierdo A, Laitman Y, Loud JT, Matrai Z, Nielsen FC, Pasini B, Pedersen IS, Singer CF, Sutter C, Tischkowitz M, Selkirk CGH, Hulick PJ, Thomassen M, Asseryanis E, Balmaña J, Chiquette J, Ehrencrona H, Garber J, Gronwald J, Hentschel J, MSc NP, Terry MB, Vega A, Yoon SY, Couch FJ, HEBON, Lee A, Rodriguez GC, Rudaitis V, van der Hout AH, Zidan J, Aittomäki K, Caldes T, Foretova L, Imyanitov EN, James P, Janavicius R, Lester J, Nguyen HP, Öfverholm A, Barile M, Domchek SM, Frost D, Jakubowska A, Neuhausen SL, Tognazzo S, van der Luijt RB, Friebel TM, Torres D, Blanco AM, Ding YC, Gehrig A, Jensen UB, John EM, Lee MH, Liljegren A, Papi L, Rantala J, Sharma P, Teixeira MR, Teulé A, Spurdle AB, Goldgar DE, Andrews L, Arason A, Bradbury AR, Evans DG, Joseph V, Pujol P, Walker L, Abugattas J, Delnatte C, Glendon G, Machackova E, Mickys U, Weber BHF, de Pauw A, EMBRACE, Karlan BY, Lázaro C, Offit K, Ramus SJ, Simard J, CIMBA Consortium, GEMO Study Collaborators, Kim SW, Mensenkamp AR, Niederacher D, Ba NP, Shah PD, Topka S, Varon-Mateeva R, Zanzottera C, Chenevix-Trench G, Weitzel JN, McGuffog L, Aalfs CM, Bonadona V, Gesta P, Hauke J, Musinsky J, MSc AP, Slavin TP, von Wachenfeldt A, Rebbeck TR, Agata S, Berger R, Collée JM, Trainer AH, Villarreal-Garza C, Huo D, Andrulis IL, Barkardottir RB, Gerdes AM, Giraud S, Kaczmarek K, Prieur F, Rogers MT, Thull DL, Wappenschmidt B, Palmero EI, Auerbach L, Eeles R, Feliubadaló L, Ngeow J, Tung N, Olah E, Arnold N, Caligo MA, Dorfling CM, Izatt L, Meijers-Heijboer HEJ, Papp J, Wang-Gohrke S, Olopade OI, Arun BK, Ferrer SF, Greene MH, Osorio A, Fowler J, Davidson R, Hahnen E, Isaacs C, Lasset C, Martínez-Bouzas C, Chung WK, Eason J, Nevanlinna H, Prajzendanc K, Sobol H, Tan YY, Varesco L, Chan TL, Caputo S, Ejlertsen B, Engel C, Ganz PA, van der Kolk LE, van Rensburg EJ, Azzollini J, Cook J, Honisch E, Lesueur F, Mari V, Peterlongo P, Rhiem K, Southey M, Nathanson KL, Barrowdale D, Dworniczak B, Giannini G, Kast K, Lu KH, Mebirouk N, Nielsen HR, Zorn KK

    Hum Mutat in press


  • Time to consider integration of a formal robotic-assisted surgical training program into obstetrics/gynecology residency curricula.

    Hade E, Vetter MH, Salani R, Palettas M, Fowler J

    J Robot Surg in press


Back to Find a Doctor Search

Make an Appointment


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Please enter a keyword (i.e. Name, Location) or choose a Cancer Type